These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7027919)

  • 21. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
    Gong JQ; Lin L; Lin T; Hao F; Zeng FQ; Bi ZG; Yi D; Zhao B
    Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Addition of bisphosphonate to antibiotic and anti-inflammatory treatment reduces bone resorption in experimental Staphylococcus aureus-induced arthritis.
    Verdrengh M; Carlsten H; Ohlsson C; Tarkowski A
    J Orthop Res; 2007 Mar; 25(3):304-10. PubMed ID: 17089391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Additive effect of an immunomodulator on the therapeutic effect of antibiotics].
    Gillissen G; Breuer-Werle M
    Pathol Biol (Paris); 1983 Jun; 31(6):548-50. PubMed ID: 6348668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of fusidic acid in therapy of experimental Staphylococcus aureus meningitis.
    Østergaard C; Yieng-Kow RV; Knudsen JD; Frimodt-Møller N; Espersen F
    J Antimicrob Chemother; 2003 May; 51(5):1301-5. PubMed ID: 12697637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced clearance of Escherichia coli and Staphylococcus aureus in mice treated with cyclophosphamide and lactoferrin.
    Artym J; Zimecki M; Kruzel ML
    Int Immunopharmacol; 2004 Sep; 4(9):1149-57. PubMed ID: 15251111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Results of 10 years of use of lincomycin (1966-1976) in the clinics of the N. N. Priorov Central Research Institute of Traumatology and Orthopedics].
    Mel'nikova VM; Markova ON; Gladshteĭn AI; Bazanova EB; Tuzova ZG
    Antibiotiki; 1978 Mar; 23(3):268-72. PubMed ID: 345962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of the amphibian peptide distinctin in a neutropenic mouse model of staphylococcal sepsis.
    Cirioni O; Ghiselli R; Orlando F; Silvestri C; De Luca S; Salzano AM; Mocchegiani F; Saba V; Scalise G; Scaloni A; Giacometti A
    Crit Care Med; 2008 Sep; 36(9):2629-33. PubMed ID: 18679116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lysostaphin as a treatment for systemic Staphylococcus aureus infection in a mouse model.
    Kokai-Kun JF; Chanturiya T; Mond JJ
    J Antimicrob Chemother; 2007 Nov; 60(5):1051-9. PubMed ID: 17848374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides.
    Cirioni O; Silvestri C; Ghiselli R; Giacometti A; Orlando F; Mocchegiani F; Chiodi L; Vittoria AD; Saba V; Scalise G
    Peptides; 2006 Nov; 27(11):2600-6. PubMed ID: 16797106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effectiveness of the inhalatory administration of chlolincocin in experimental staphylococcal pneumonia].
    Fateeva LI; Poliak MS
    Antibiotiki; 1976 Jun; 21(6):536-40. PubMed ID: 942193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic-induced persistence of cytotoxic Staphylococcus aureus in non-phagocytic cells.
    Krut O; Sommer H; Krönke M
    J Antimicrob Chemother; 2004 Feb; 53(2):167-73. PubMed ID: 14729736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Contribution to the rational treatment of staphylococcal osteomyelitis with lincomycin].
    Vacek V; Hejzlar M; Pavlanský R
    Cas Lek Cesk; 1968 Dec; 107(50):1505-14. PubMed ID: 5711202
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antibiotic lincomycin].
    Chernomordik AB
    Antibiotiki; 1968 Dec; 13(12):1130-5. PubMed ID: 4894135
    [No Abstract]   [Full Text] [Related]  

  • 34. [The new antibiotic lincomycin].
    Mussgnug G
    Arzneimittelforschung; 1967 Jul; 17(7):866-70. PubMed ID: 5632846
    [No Abstract]   [Full Text] [Related]  

  • 35. Altered immune response to staphylococcal antigens in long-lasting implanted mice.
    Sadowska B; Zoładek J; Ljungh A; Rudnicka W; Rózalska B
    Acta Microbiol Pol; 1997; 46(3):253-61. PubMed ID: 9429295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The therapeutic potential of the lincomycin antibiotics.
    Holloway WJ
    Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):321-4. PubMed ID: 5579251
    [No Abstract]   [Full Text] [Related]  

  • 37. Protective effects of synthetic antibacterial oligopeptides based on the insect defensins on Methicillin-resistant Staphylococcus aureus in mice.
    Saido-Sakanaka H; Ishibashi J; Momotani E; Yamakawa M
    Dev Comp Immunol; 2005; 29(5):469-77. PubMed ID: 15707667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lysostaphin: an antistaphylococcal agent.
    Kumar JK
    Appl Microbiol Biotechnol; 2008 Sep; 80(4):555-61. PubMed ID: 18607587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lysostaphin eradicates established Staphylococcus aureus biofilms in jugular vein catheterized mice.
    Kokai-Kun JF; Chanturiya T; Mond JJ
    J Antimicrob Chemother; 2009 Jul; 64(1):94-100. PubMed ID: 19398455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental study on the efficacy of combinations of glycopeptides and beta-lactams against Staphylococcus aureus with reduced susceptibility to glycopeptides.
    Domenech A; Ribes S; Cabellos C; Taberner F; Tubau F; Domínguez MA; Montero A; Liñares J; Ariza J; Gudiol F
    J Antimicrob Chemother; 2005 Oct; 56(4):709-16. PubMed ID: 16120625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.